Company: PIII
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001628280-25-015305
Chunk: 162

Company: P3 Health Partners Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 7
Chunk 162
---
iluted$(1.08)$(0.63)WEIGHTED AVERAGE COMMON SHARES OUTSTANDING (Note 16):Basic145,175 94,889 Diluted146,998 294,590 

See accompanying notes to consolidated financial statements.

P3 Health Partners Inc. | 2024 Form 10-K | 80

P3 HEALTH PARTNERS INC. and SUBSIDIARIES 

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY AND MEZZANINE EQUITY

(in thousands)

RedeemableNon-controllingInterestClass A Common StockClass V Common StockAdditional Paid in CapitalAccumulatedDeficitTotal Stockholders’EquitySharesAmountSharesAmountSTOCKHOLDERS’ EQUITY, December 31, 2022$516,805 41,579 $4 201,592 $20 $315,375 $(309,545)$5,854 Cumulative adjustment due to adoption of new credit loss standard(124)—— —— — (26)(26)Exchanges of redeemable non-controlling interest for Class A common stock—5,3711 (5,371)(1)— —— Vesting of Class V common stock awards——— 348 1 (1)—— Issuance of Class A common stock upon settlement of restricted stock units, net of shares withheld for tax—204———(16)—(16)Issuance of restricted stock awards —250—————— At-the-market sales, net of offering costs—27———33—33 Equity-based compensation785————5,194—5,194 Restricted stock unit awards issued in satisfaction of executive transaction bonuses—————5,000—5,000 Fair value adjustment to redeemable non-controlling interest20,579 ————(20,579)—(20,579)Remeasurement adjustment to redeemable non-controlling interest resulting from ownership changes(117,860)— — — — 117,860 — 117,860 Private placement, net of offering costs—69,1577——86,576—86,583 Net loss(128,653)— — — — — (57,773)(57,773)STOCKHOLDERS’ EQUITY, December 31, 2023291,532 116,588 12 196,569 20 509